
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
Samantha Meltzer‐Brody, Stephen Kanes
Neurobiology of Stress (2020) Vol. 12, pp. 100212-100212
Open Access | Times Cited: 102
Samantha Meltzer‐Brody, Stephen Kanes
Neurobiology of Stress (2020) Vol. 12, pp. 100212-100212
Open Access | Times Cited: 102
Showing 1-25 of 102 citing articles:
Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome
Lara Tiranini, Rossella E. Nappi
Faculty Reviews (2022) Vol. 11
Open Access | Times Cited: 72
Lara Tiranini, Rossella E. Nappi
Faculty Reviews (2022) Vol. 11
Open Access | Times Cited: 72
Structural insights into opposing actions of neurosteroids on GABAA receptors
Dagimhiwat Legesse, Chen Fan, Jinfeng Teng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40
Dagimhiwat Legesse, Chen Fan, Jinfeng Teng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40
Postpartum Depression: Current Status and Possible Identification Using Biomarkers
Yi Yu, Hong-Feng Liang, Jing Chen, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 68
Yi Yu, Hong-Feng Liang, Jing Chen, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 68
Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
Riah Patterson, Irina Balan, A. Leslie Morrow, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 67-72
Open Access | Times Cited: 32
Riah Patterson, Irina Balan, A. Leslie Morrow, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 67-72
Open Access | Times Cited: 32
Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
Scott M. Thompson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 83-95
Closed Access | Times Cited: 29
Scott M. Thompson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 83-95
Closed Access | Times Cited: 29
Neurosteroids: mechanistic considerations and clinical prospects
Jamie Maguire, Steven Mennerick
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 73-82
Open Access | Times Cited: 26
Jamie Maguire, Steven Mennerick
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 73-82
Open Access | Times Cited: 26
Activation of σ-1 receptor mitigates estrogen withdrawal-induced anxiety/depressive-like behavior in mice via restoration of GABA/glutamate signaling and neuroplasticity in the hippocampus
Peng Ren, Jingya Wang, Honglei Chen, et al.
Journal of Pharmacological Sciences (2024) Vol. 154, Iss. 4, pp. 236-245
Open Access | Times Cited: 9
Peng Ren, Jingya Wang, Honglei Chen, et al.
Journal of Pharmacological Sciences (2024) Vol. 154, Iss. 4, pp. 236-245
Open Access | Times Cited: 9
Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience
Bernhard Lüscher, Hanns Möhler
F1000Research (2019) Vol. 8, pp. 751-751
Open Access | Times Cited: 71
Bernhard Lüscher, Hanns Möhler
F1000Research (2019) Vol. 8, pp. 751-751
Open Access | Times Cited: 71
Sex and COVID-19: A Protective Role for Reproductive Steroids
Graziano Pinna
Trends in Endocrinology and Metabolism (2020) Vol. 32, Iss. 1, pp. 3-6
Open Access | Times Cited: 59
Graziano Pinna
Trends in Endocrinology and Metabolism (2020) Vol. 32, Iss. 1, pp. 3-6
Open Access | Times Cited: 59
Hippocampus‐based behavioral, structural, and molecular dynamics across the estrous cycle
Devin Rocks, Marija Kundaković
Journal of Neuroendocrinology (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 28
Devin Rocks, Marija Kundaković
Journal of Neuroendocrinology (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 28
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
Doodipala Samba Reddy, Robert H. Mbilinyi, Emily R. Estes
Psychopharmacology (2023) Vol. 240, Iss. 9, pp. 1841-1863
Open Access | Times Cited: 20
Doodipala Samba Reddy, Robert H. Mbilinyi, Emily R. Estes
Psychopharmacology (2023) Vol. 240, Iss. 9, pp. 1841-1863
Open Access | Times Cited: 20
Neurosteroid enantiomers as potentially novel neurotherapeutics
Douglas F. Covey, Alex S. Evers, Yukitoshi Izumi, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105191-105191
Open Access | Times Cited: 19
Douglas F. Covey, Alex S. Evers, Yukitoshi Izumi, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105191-105191
Open Access | Times Cited: 19
Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression
Jerry Guintivano, Enda M. Byrne, Jacqueline Kiewa, et al.
American Journal of Psychiatry (2023) Vol. 180, Iss. 12, pp. 884-895
Open Access | Times Cited: 17
Jerry Guintivano, Enda M. Byrne, Jacqueline Kiewa, et al.
American Journal of Psychiatry (2023) Vol. 180, Iss. 12, pp. 884-895
Open Access | Times Cited: 17
Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?
Graziano Pinna
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 40
Graziano Pinna
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 40
Allopregnanolone in mood disorders: Mechanism and therapeutic development
Shiyi Chen, Lijuan Gao, Xiaoyu Li, et al.
Pharmacological Research (2021) Vol. 169, pp. 105682-105682
Closed Access | Times Cited: 38
Shiyi Chen, Lijuan Gao, Xiaoyu Li, et al.
Pharmacological Research (2021) Vol. 169, pp. 105682-105682
Closed Access | Times Cited: 38
GABA System Modifications During Periods of Hormonal Flux Across the Female Lifespan
Rachel A Gilfarb, Benedetta Leuner
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Rachel A Gilfarb, Benedetta Leuner
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Allopregnanolone in Postpartum Depression
Graziano Pinna, Felipe Borges Almeida, John M. Davis
Frontiers in Global Women s Health (2022) Vol. 3
Open Access | Times Cited: 25
Graziano Pinna, Felipe Borges Almeida, John M. Davis
Frontiers in Global Women s Health (2022) Vol. 3
Open Access | Times Cited: 25
Progestogen-Mediated Neuroprotection in Central Nervous System Disorders
Taysa Bervian Bassani, Cynthia Silva Bartolomeo, Rafaela Brito Oliveira, et al.
Neuroendocrinology (2022) Vol. 113, Iss. 1, pp. 14-35
Open Access | Times Cited: 22
Taysa Bervian Bassani, Cynthia Silva Bartolomeo, Rafaela Brito Oliveira, et al.
Neuroendocrinology (2022) Vol. 113, Iss. 1, pp. 14-35
Open Access | Times Cited: 22
Sex and hormonal status influence the anxiolytic-like effect of oxytocin in mice
Khalin E. Nisbett, Luis Antonio Pérez González, Marina Teruel, et al.
Neurobiology of Stress (2023) Vol. 26, pp. 100567-100567
Open Access | Times Cited: 14
Khalin E. Nisbett, Luis Antonio Pérez González, Marina Teruel, et al.
Neurobiology of Stress (2023) Vol. 26, pp. 100567-100567
Open Access | Times Cited: 14
Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development
Qian Gao, Wei Sun, Yue-Rui Wang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
Qian Gao, Wei Sun, Yue-Rui Wang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder
Christopher Sikes-Keilp, David R. Rubinow
CNS Drugs (2023) Vol. 37, Iss. 8, pp. 679-693
Closed Access | Times Cited: 13
Christopher Sikes-Keilp, David R. Rubinow
CNS Drugs (2023) Vol. 37, Iss. 8, pp. 679-693
Closed Access | Times Cited: 13
Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review
Rafał Marecki, Joanna Kałuska, Agata Kolanek, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
Rafał Marecki, Joanna Kałuska, Agata Kolanek, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
New Directions in Neurosteroid Therapeutics in Neuropsychiatry
Charles F. Zorumski, Douglas F. Covey, Yukitoshi Izumi, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106119-106119
Open Access
Charles F. Zorumski, Douglas F. Covey, Yukitoshi Izumi, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106119-106119
Open Access
Maternal neuroplasticity and mental health during the transition to motherhood
Natalia Chechko, Susanne Nehls
Nature Mental Health (2025)
Closed Access
Natalia Chechko, Susanne Nehls
Nature Mental Health (2025)
Closed Access
PPAR-α Hypermethylation in the Hippocampus of Mice Exposed to Social Isolation Stress Is Associated with Enhanced Neuroinflammation and Aggressive Behavior
Francesco Matrisciano, Graziano Pinna
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10678-10678
Open Access | Times Cited: 28
Francesco Matrisciano, Graziano Pinna
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10678-10678
Open Access | Times Cited: 28